• Home
  • Exclusives
Filter by Topic
  • 3D Printing
  • Aesthetics
  • AI
  • Algorithm
  • APAC
  • Aquisition
  • AR/VR
  • ASC
  • Audiology
  • Biotech
  • Cardiology
    • Heart Failure
  • Cardiovasular
  • Careers
    • Leadership
    • Talent
  • Catheters
  • CE Mark
  • Clinical Study
  • Clinical Trial
  • Commercial Launch
  • Contract Manufacturing
    • Manufacturing
  • Dentistry
  • Dermatology
  • Diabetes
  • Diagnostics
  • Dialysis
  • Digital Health
  • Digital Therapeutics
  • Drug-delivery
  • EMS
  • Endoscopy
  • Endovascular
  • ENT
  • EUA
  • European Comission
  • Expansion
  • FDA
  • FDA Approved
  • FDA Cleared
  • FDA STeP
  • FIH
  • Funding
    • VC/PE
  • Gastroenterology
  • Genomics
  • Healthcare
  • Hematology
  • Hepatology
  • IDE
  • Imaging
  • Immunotherapy
  • Implantables
  • IVF
  • Life Science
  • M&A
  • Machine Learning
  • Medical Education
  • MedTech
  • Mental Health
  • Milestone
  • Nephrology
  • Neuro
  • Neurovascular
  • Oncology
  • Ophthalmology
  • Orthopedic
  • Otolaryngolog
  • Pain Management
  • Pancreatology
  • Patent
  • Patient Monitoring
  • Pediatrics
  • PFA
  • Pharmaceutical
  • Point-of-Care Testing
  • Policy & Regulation
  • prosthetic
  • Public Offering
  • Pulmonary
  • R&D
  • Radiology
  • Reimnbursement
  • Respiratory
  • Robotics
  • SaMD
  • Sensors
  • Sleep Apnea
  • Software
  • Spine
  • Start-Up
  • Sterilization
  • Stocks
  • Strategic Partnership
  • Structural Heart
  • Surgery
    • Laparoscopic
    • Minimally Invasive
  • Surgical Robotics
  • Surgical Visualization
  • Telehealth
  • Therapeutics
  • Transplant Tech
  • Uncategorized
  • Urology
  • Vascular
  • Virology
  • Wearables
  • Women's Health
  • Wound Care
Saved
  • Home
  • Exclusives
Filter by Topic
  • 3D Printing
  • Aesthetics
  • AI
  • Algorithm
  • APAC
  • Aquisition
  • AR/VR
  • ASC
  • Audiology
  • Biotech
  • Cardiology
    • Heart Failure
  • Cardiovasular
  • Careers
    • Leadership
    • Talent
  • Catheters
  • CE Mark
  • Clinical Study
  • Clinical Trial
  • Commercial Launch
  • Contract Manufacturing
    • Manufacturing
  • Dentistry
  • Dermatology
  • Diabetes
  • Diagnostics
  • Dialysis
  • Digital Health
  • Digital Therapeutics
  • Drug-delivery
  • EMS
  • Endoscopy
  • Endovascular
  • ENT
  • EUA
  • European Comission
  • Expansion
  • FDA
  • FDA Approved
  • FDA Cleared
  • FDA STeP
  • FIH
  • Funding
    • VC/PE
  • Gastroenterology
  • Genomics
  • Healthcare
  • Hematology
  • Hepatology
  • IDE
  • Imaging
  • Immunotherapy
  • Implantables
  • IVF
  • Life Science
  • M&A
  • Machine Learning
  • Medical Education
  • MedTech
  • Mental Health
  • Milestone
  • Nephrology
  • Neuro
  • Neurovascular
  • Oncology
  • Ophthalmology
  • Orthopedic
  • Otolaryngolog
  • Pain Management
  • Pancreatology
  • Patent
  • Patient Monitoring
  • Pediatrics
  • PFA
  • Pharmaceutical
  • Point-of-Care Testing
  • Policy & Regulation
  • prosthetic
  • Public Offering
  • Pulmonary
  • R&D
  • Radiology
  • Reimnbursement
  • Respiratory
  • Robotics
  • SaMD
  • Sensors
  • Sleep Apnea
  • Software
  • Spine
  • Start-Up
  • Sterilization
  • Stocks
  • Strategic Partnership
  • Structural Heart
  • Surgery
    • Laparoscopic
    • Minimally Invasive
  • Surgical Robotics
  • Surgical Visualization
  • Telehealth
  • Therapeutics
  • Transplant Tech
  • Uncategorized
  • Urology
  • Vascular
  • Virology
  • Wearables
  • Women's Health
  • Wound Care
Saved

Topic: Oncology

article icon article
Diagnostics FDA Approved Hematology Oncology Vascular

Abbott rolls out SimpleScreen colorectal cancer blood test developed by Freenome

Abbott (NYSE:ABT) has begun rolling out a blood test to help screen for colorectal cancer […]

article icon article
APAC Funding Oncology

Merck pens $2.1B deal with China’s SciBrunch to chase KRAS G12D

Merck & Co. has become the latest pharma to jump on the KRAS G12D bandwagon, […]

article icon article
Aquisition Diagnostics Oncology

Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients

DEER PARK, Ill., Sept. 28, 2026 /PRNewswire/ — Leica Biosystems, a Danaher company (the “Company”) […]

article icon article
AI Diagnostics Oncology

Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

SEOUL, South Korea, Sept. 28, 2026 /PRNewswire/ — Lunit (KRX:328130), a leading provider of AI […]

article icon article
Oncology

Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040

SAN JOSE, Calif., Sept. 21, 2026 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: […]

article icon article
Diagnostics FDA Cleared Gastroenterology Oncology

Neptune Medical’s robotic colonoscopy system obtains FDA clearance

Neptune Medical has landed an FDA clearance for its robotic system designed to provide stable […]

article icon article
Oncology Strategic Partnership

Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray’s Online Adaptive Capabilities

MADISON, Wis., Sept. 11, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems […]

article icon article
Dermatology Diagnostics Oncology

DermaSensor forges partnerships to advance its skin cancer detection tech

DermaSensor today announced four new partnerships to accelerate growth of its skin-cancer-detecting device. Earlier this year, […]

article icon article
Funding Oncology Urology

MaxQ Medical Raises $31.5 Million Series A, Backed by Olympus, to Advance its Prostate Care Platform

SUNNYVALE, Calif., Aug. 20, 2026 /PRNewswire/ — MaxQ Medical, Inc., a private health-tech company developing an all-in-one transurethral […]

article icon article
Diagnostics FDA Cleared Oncology

Maverix Medical Announces FDA 510(k) Clearance for the Narwhal™ Cryo System

MENLO PARK, Calif., Aug. 20, 2026 /PRNewswire/ — Maverix Medical, a company focused on revolutionizing the diagnosis […]

article icon article
Diagnostics Neuro Oncology

Monteris Medical study shows critical survival factors for brain tumor patients

Data from Monteris Medical’s new post-market study published in the Journal of Clinical Oncology demonstrates that extent of […]

article icon article
FDA Cleared Oncology Respiratory

Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software

Johnson & Johnson MedTech (NYSE: JNJ) today announced the launch of Monarch Quest 3, the […]

article icon article
Oncology Robotics Surgical Robotics

Noah Medical launches next-gen software for robotic-assisted bronchoscopy

Noah Medical has launched its Galaxy II software, the next evolution of the company’s robotic-assisted bronchoscopy […]

article icon article
AI Oncology Respiratory

Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway

OXFORD, England and SEOUL, South Korea, Aug. 13, 2026 /PRNewswire/ — Optellum and Coreline Soft today announced their intent to collaborate […]

article icon article
Drug-delivery Funding Oncology

Ceramedix Awarded Up to $4.5 Million NIAID Contract to Advance Lead GI-ARS Therapeutic Toward IND Submission

LONG ISLAND CITY, N.Y., Aug. 11, 2026 /PRNewswire/ — Ceramedix, Inc., a privately held New York City-based […]

article icon article
Diagnostics Oncology

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

NEW YORK, Aug. 5, 2026 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical […]

article icon article
Oncology Urology

Francis Medical Announces Northwell Urology Group Performs First Commercial Vanquish® Water Vapor Ablation Procedure in New York

LAKE SUCCESS, N.Y., Aug. 5, 2026 /PRNewswire/ — Samir S. Taneja, MD, a urologic oncologist, chairman of […]

article icon article
Diagnostics Imaging Oncology

Tennessee Oncology Opens New State-of-the-Art Tullahoma Medical Center

NASHVILLE, Tenn., Aug. 3, 2026 /PRNewswire/ — Tennessee Oncology, which treats nearly half the cancer patients in […]

article icon article
FDA Cleared Imaging Oncology Radiology

GE HealthCare launches new breast imaging systems

GE HealthCare (Nasdaq:GEHC) announced today that it launched its new Invenia ABUS Prime and ABUS StreamVue […]

article icon article
FDA Approved Oncology

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

LONDON, July 22, 2026 /PRNewswire/ — GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration […]

article icon article
Aquisition Diagnostics Oncology

Leica Biosystems to Acquire StatLab

DEER PARK, Ill., July 14, 2026 /PRNewswire/ — Leica Biosystems, an operating company of Danaher (the “Company”), […]

article icon article
AI Diagnostics Oncology Strategic Partnership

Nucs AI and Segmed Partner to Build the Data Foundation for Precision Oncology

NEW YORK, July 14, 2026 /PRNewswire/ — Nucs AI, a company developing AI-powered diagnostic and predictive imaging […]

article icon article
Commercial Launch Oncology

Egg Medical launches next-gen radiation protection device

Egg Medical announced today that it launched its EggNest Complete 2.0 advanced enhanced radiation protection device […]

article icon article
Diagnostics FDA Approved Oncology

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

BURLINGTON, N.C. and ST. LOUIS, June 22, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive […]

article icon article
Imaging Oncology Surgery

XEOS Announces Publication of Landmark BrIMA Study in JAMA Surgery Demonstrating Significant Improvement in Intraoperative Margin Assessment with Specimen PET-CT

GHENT, Belgium, June 18, 2026 /PRNewswire/ — XEOS, a medical technology company advancing intraoperative molecular imaging, today […]

article icon article
Clinical Study FDA Oncology

AngioDynamics wins FDA IDE for feasibility study of NanoKnife in BPH

AngioDynamics (Nasdaq:ANGO) announced today that it received FDA investigational device exemption (IDE) to initiate the RELIEF […]

article icon article
CE Mark Diagnostics Oncology

DermaSensor wins CE mark for skin cancer detection device

DermaSensor announced today that it received Class IIb CE mark approval for its skin cancer detection […]

article icon article
Funding Neuro Oncology

GT Medical Technologies Completes Oversubscribed $100 Million Series E Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors

TEMPE, Ariz., June 9, 2026 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to […]

article icon article
Commercial Launch Diagnostics Oncology

Metropolitan Dermatology Introduces Nevisense® Technology for Advanced Melanoma Detection

CLARK, N.J., June 8, 2026 /PRNewswire/ — Metropolitan Dermatology is proud to announce the addition of Nevisense®, a […]

article icon article
CE Mark Diagnostics Oncology

Mammotome Expands Access to Innovative Breast Biopsy Site Marker

QUICKBORN, Germany, June 4, 2026 /PRNewswire/ — Mammotome, a Danaher company and global leader in breast care […]

article icon article
Imaging Oncology Radiology

Philips introduces SmartIQ imaging tech for Azurion image-guided therapy

Philips (NYSE:PHG) today unveiled SmartIQ, its coronary imaging technology for the Azurion image-guided therapy platform. Amsterdam-based Philips developed […]

article icon article
Diagnostics Oncology Strategic Partnership

CancerCheck and Evexia Partner to Make Early, Accurate Cancer Detection a Reality

DALLAS, May 14, 2026 /PRNewswire/ — Cancer Check Labs, creator of CancerCheck, a one-of-a-kind multi-cancer early detection […]

article icon article
Commercial Launch Funding Oncology Strategic Partnership

Valion Bio’s Velocity Bioworks Secures Exclusive Commercial License to LarmorBio’s BioScan-NMR™ Platform

SAN ANTONIO, May 14, 2026 /PRNewswire/ — Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) (Nasdaq: VBIO), a […]

article icon article
Diagnostics Hematology Oncology

DELFI Diagnostics to Present First Clinical Utility Data for Blood-Based Lung Cancer Screening at ATS 2026 International Conference

PALO ALTO, Calif., May 13, 2026 /PRNewswire/ — DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage cell-free […]

article icon article
Aquisition Oncology

CQ Medical® Enhances Patient-Specific Cancer Treatment Capabilities Through .decimal® Acquisition

AVONDALE, Pa., May 5, 2026 /PRNewswire/ — CQ Medical, the global leader in patient radiotherapy positioning and […]

article icon article
Digital Health Digital Therapeutics Imaging Oncology

Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer

PALO ALTO, Calif., May 1, 2026 /PRNewswire/ — Sonire Therapeutics, a U.S.-based clinical-stage medical device company, today announced […]

article icon article
Diagnostics FDA Cleared Oncology

Utepreva Introduces FDA 510(k)-Cleared Endometrial Sampler Designed to Support Early Detection of Endometrial Cancer

NEW YORK, April 22, 2026 /PRNewswire/ — Utepreva LLC today announced the launch of the Utepreva Endometrial Sampler, a […]

article icon article
Diagnostics Funding Oncology Public Offering

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

NEW YORK, April 23, 2026 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical […]

article icon article
AI Diagnostics Oncology

Nanostics Announces Publication of a ClarityDX Prostate Study Validating New Algorithms with Improved Cancer Prediction that make MRI or DRE Optional

EDMONTON, AB, April 20, 2026 /PRNewswire/ – Nanostics Inc., a precision health company advancing diagnostic innovation through its […]

  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »

Original post by MassDevice

Written by: Conor Hale

Newsletter

Get industry insight and medtech news delivered to your inbox every week.

Sign up

Newsletter

Get industry insight and medtech news delivered to your inbox every week.

Follow us
  • LinkedIn icon Follow us on LinkedIn
  • YouTube icon Follow us on YouTube
TMG Pulse

© Copyright 2020. The Mullings Group. All Rights Reserved.

Notice: Most of the content on this page is produced by third party media organizations and is subject to individual copyright. We do not claim ownership to any content published by another entity. If you are a news organization in the medical technology sector who would like to repost an article. Please reach out to the original author.

Powered by Qwark Labs

Back to top Privacy Policy
  • LinkedIn icon
  • YouTube icon
The Mullings Group Dragonfly Inside TMG TrueFuture
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT